Issue navigation
Volume 75, Issue 11, November 2020
Review
Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3087–3095, https://doi.org/10.1093/jac/dkaa205
For debate
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: when management reasoning eclipses evidence-based medicine
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3096–3098, https://doi.org/10.1093/jac/dkaa281
Systematic reviews
Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: a systematic review
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3099–3108, https://doi.org/10.1093/jac/dkaa257
Treatment efficacy for pharyngeal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3109–3119, https://doi.org/10.1093/jac/dkaa300
Original research
Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3120–3125, https://doi.org/10.1093/jac/dkaa297
Studies on the role of IS1216E in the formation and dissemination of poxtA-carrying plasmids in an Enterococcus faecium clade A1 isolate
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3126–3130, https://doi.org/10.1093/jac/dkaa325
A novel community-acquired MRSA clone, USA300-LV/J, uniquely evolved in Japan
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3131–3134, https://doi.org/10.1093/jac/dkaa313
Microevolution of acquired colistin resistance in Enterobacteriaceae from ICU patients receiving selective decontamination of the digestive tract
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3135–3143, https://doi.org/10.1093/jac/dkaa305
A genome-wide analysis of Escherichia coli responses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate degradation and phosphate transport systems
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3144–3151, https://doi.org/10.1093/jac/dkaa296
Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3152–3155, https://doi.org/10.1093/jac/dkaa302
Genomic background of the Klebsiella pneumoniae NDM-1 outbreak in Poland, 2012–18
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3156–3162, https://doi.org/10.1093/jac/dkaa339
Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015–16
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3163–3172, https://doi.org/10.1093/jac/dkaa318
Extensive antimicrobial resistance mobilization via multicopy plasmid encapsidation mediated by temperate phages
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3173–3180, https://doi.org/10.1093/jac/dkaa311
Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3181–3188, https://doi.org/10.1093/jac/dkaa316
Enhanced efficacy of endonuclease inhibitor baloxavir acid against orthobunyaviruses when used in combination with ribavirin
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3189–3193, https://doi.org/10.1093/jac/dkaa337
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3194–3201, https://doi.org/10.1093/jac/dkaa307
Utility of MALDI-TOF MS for differentiation of Neisseria gonorrhoeae isolates with dissimilar azithromycin susceptibility profiles
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3202–3208, https://doi.org/10.1093/jac/dkaa303
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3209–3217, https://doi.org/10.1093/jac/dkaa291
Evaluation of standardized automated rapid antimicrobial susceptibility testing of Enterobacterales-containing blood cultures: a proof-of-principle study
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3218–3229, https://doi.org/10.1093/jac/dkaa336
EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3230–3238, https://doi.org/10.1093/jac/dkaa333
Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3239–3243, https://doi.org/10.1093/jac/dkaa306
High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3244–3247, https://doi.org/10.1093/jac/dkaa322
A novel in silico antimicrobial peptide DP7 combats MDR Pseudomonas aeruginosa and related biofilm infections
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3248–3259, https://doi.org/10.1093/jac/dkaa308
Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3260–3268, https://doi.org/10.1093/jac/dkaa314
Clofazimine pharmacokinetics in patients with TB: dosing implications
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3269–3277, https://doi.org/10.1093/jac/dkaa310
Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3278–3285, https://doi.org/10.1093/jac/dkaa294
Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3286–3292, https://doi.org/10.1093/jac/dkaa312
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3293–3302, https://doi.org/10.1093/jac/dkaa320
Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3303–3310, https://doi.org/10.1093/jac/dkaa299
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3311–3318, https://doi.org/10.1093/jac/dkaa309
Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3319–3326, https://doi.org/10.1093/jac/dkaa343
Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3327–3333, https://doi.org/10.1093/jac/dkaa319
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3334–3343, https://doi.org/10.1093/jac/dkaa292
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3344–3348, https://doi.org/10.1093/jac/dkaa330
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3349–3358, https://doi.org/10.1093/jac/dkaa304
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3359–3365, https://doi.org/10.1093/jac/dkaa321
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3366–3372, https://doi.org/10.1093/jac/dkaa331
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3373–3378, https://doi.org/10.1093/jac/dkaa332
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3379–3385, https://doi.org/10.1093/jac/dkaa334
Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3386–3390, https://doi.org/10.1093/jac/dkaa326
High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3391–3394, https://doi.org/10.1093/jac/dkaa315
Research letters
Identification of a novel optrA-harbouring transposon, Tn6823, in Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3395–3397, https://doi.org/10.1093/jac/dkaa323
A novel plasmid-borne tet(X6) variant co-existing with blaNDM-1 and blaOXA-58 in a chicken Acinetobacter baumannii isolate
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3397–3399, https://doi.org/10.1093/jac/dkaa342
Co-existence of plasmid-mediated tigecycline and colistin resistance genes tet(X4) and mcr-1 in a community-acquired Escherichia coli isolate in China
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3400–3402, https://doi.org/10.1093/jac/dkaa317
Emergence of blood infections caused by carbapenemase-producing Klebsiella pneumoniae ST307 in Spain
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3402–3405, https://doi.org/10.1093/jac/dkaa301
Variants in ampD and dacB lead to in vivo resistance evolution of Pseudomonas aeruginosa within the central nervous system
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3405–3408, https://doi.org/10.1093/jac/dkaa324
Antibiotic-induced myasthenia worsening—an estimation of risk based on reporting frequency
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3408–3410, https://doi.org/10.1093/jac/dkaa298
COVID-19, antibiotics and One Health: a UK environmental risk assessment
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3411–3412, https://doi.org/10.1093/jac/dkaa338
